Search

Leszek B Kiliman

Examiner (ID: 1930, Phone: (571)272-1509 , Office: P/1788 )

Most Active Art Unit
1773
Art Unit(s)
1788, 1787, 1509, 1316, 1773, 1794
Total Applications
2689
Issued Applications
2219
Pending Applications
93
Abandoned Applications
377

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17334576 [patent_doc_number] => 20220000907 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-06 [patent_title] => MOUTHWASH/GARGLE, NASAL/ORAL/NASAL SPRAY COVID AND BACTERIOCIDE ARRANGEMENT [patent_app_type] => utility [patent_app_number] => 17/189455 [patent_app_country] => US [patent_app_date] => 2021-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7157 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17189455 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/189455
MOUTHWASH/GARGLE, NASAL/ORAL/NASAL SPRAY COVID AND BACTERIOCIDE ARRANGEMENT Mar 1, 2021 Abandoned
Array ( [id] => 16899109 [patent_doc_number] => 20210178025 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-17 [patent_title] => ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES [patent_app_type] => utility [patent_app_number] => 17/188634 [patent_app_country] => US [patent_app_date] => 2021-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6145 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17188634 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/188634
ANTIMICROBIAL COATINGS FOR MEDICAL DEVICES Feb 28, 2021 Abandoned
Array ( [id] => 16898838 [patent_doc_number] => 20210177754 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-17 [patent_title] => NANOEMULSION FOR ORAL USE [patent_app_type] => utility [patent_app_number] => 17/185087 [patent_app_country] => US [patent_app_date] => 2021-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16153 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17185087 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/185087
NANOEMULSION FOR ORAL USE Feb 24, 2021 Pending
Array ( [id] => 19134593 [patent_doc_number] => 11969502 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-04-30 [patent_title] => Oral products [patent_app_type] => utility [patent_app_number] => 17/183580 [patent_app_country] => US [patent_app_date] => 2021-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 23164 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17183580 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/183580
Oral products Feb 23, 2021 Issued
Array ( [id] => 17050517 [patent_doc_number] => 20210259951 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-26 [patent_title] => Transmucosal Drug Delivery System [patent_app_type] => utility [patent_app_number] => 17/177430 [patent_app_country] => US [patent_app_date] => 2021-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7809 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 132 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17177430 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/177430
Transmucosal Drug Delivery System Feb 16, 2021 Pending
Array ( [id] => 16990058 [patent_doc_number] => 20210228478 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-29 [patent_title] => TRANEXAMIC ACID SPRAY FOR KNEE ARTHROPLASTY [patent_app_type] => utility [patent_app_number] => 17/169403 [patent_app_country] => US [patent_app_date] => 2021-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4447 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17169403 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/169403
TRANEXAMIC ACID SPRAY FOR KNEE ARTHROPLASTY Feb 5, 2021 Pending
Array ( [id] => 16990058 [patent_doc_number] => 20210228478 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-29 [patent_title] => TRANEXAMIC ACID SPRAY FOR KNEE ARTHROPLASTY [patent_app_type] => utility [patent_app_number] => 17/169403 [patent_app_country] => US [patent_app_date] => 2021-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4447 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17169403 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/169403
TRANEXAMIC ACID SPRAY FOR KNEE ARTHROPLASTY Feb 5, 2021 Pending
Array ( [id] => 17005271 [patent_doc_number] => 20210236432 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-05 [patent_title] => COMPOSITIONS COMPRISING ROFLUMILAST FOR TREATING HIDRADENITIS SUPPURATIVA AND PRURIGO NODULARIS [patent_app_type] => utility [patent_app_number] => 17/166336 [patent_app_country] => US [patent_app_date] => 2021-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6365 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17166336 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/166336
COMPOSITIONS COMPRISING ROFLUMILAST FOR TREATING HIDRADENITIS SUPPURATIVA AND PRURIGO NODULARIS Feb 2, 2021 Abandoned
Array ( [id] => 16853362 [patent_doc_number] => 20210154107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-27 [patent_title] => PARTICLES CONTAINING COLORING AGENTS AND METHODS OF USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/164308 [patent_app_country] => US [patent_app_date] => 2021-02-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23610 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -50 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17164308 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/164308
PARTICLES CONTAINING COLORING AGENTS AND METHODS OF USING THE SAME Jan 31, 2021 Pending
Array ( [id] => 16990633 [patent_doc_number] => 20210229053 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-29 [patent_title] => AMINO ACID SURFACTANTS [patent_app_type] => utility [patent_app_number] => 17/154919 [patent_app_country] => US [patent_app_date] => 2021-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4227 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17154919 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/154919
AMINO ACID SURFACTANTS Jan 20, 2021 Pending
Array ( [id] => 17290839 [patent_doc_number] => 20210386678 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-16 [patent_title] => BIOPOLYMER-ENCAPSULATED GLYCOSYL TRANSFERASE INHIBITOR COMPOSITIONS AND METHODS FOR TREATING DIABETES AND CARDIAC INDICATIONS [patent_app_type] => utility [patent_app_number] => 17/152708 [patent_app_country] => US [patent_app_date] => 2021-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15328 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -37 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17152708 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/152708
BIOPOLYMER-ENCAPSULATED GLYCOSYL TRANSFERASE INHIBITOR COMPOSITIONS AND METHODS FOR TREATING DIABETES AND CARDIAC INDICATIONS Jan 18, 2021 Abandoned
Array ( [id] => 18232076 [patent_doc_number] => 11596618 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-03-07 [patent_title] => Oral cannabinoid delivery formulations with mouthfeel experience enhancers [patent_app_type] => utility [patent_app_number] => 17/150418 [patent_app_country] => US [patent_app_date] => 2021-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15675 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17150418 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/150418
Oral cannabinoid delivery formulations with mouthfeel experience enhancers Jan 14, 2021 Issued
Array ( [id] => 16961596 [patent_doc_number] => 20210213095 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-15 [patent_title] => COMPOSITIONS AND METHODS FOR ACTIVATING CELLULAR SIGNALING PATHWAYS [patent_app_type] => utility [patent_app_number] => 17/148448 [patent_app_country] => US [patent_app_date] => 2021-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23764 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17148448 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/148448
COMPOSITIONS AND METHODS FOR ACTIVATING CELLULAR SIGNALING PATHWAYS Jan 12, 2021 Abandoned
Array ( [id] => 17748275 [patent_doc_number] => 20220226478 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-21 [patent_title] => FILM-FORMING COMPOSITION CONTAINING GELLAN GUM AND STARCH, AND APPLICATION IN SOFT CAPSULE [patent_app_type] => utility [patent_app_number] => 17/614644 [patent_app_country] => US [patent_app_date] => 2020-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7079 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17614644 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/614644
FILM-FORMING COMPOSITION CONTAINING GELLAN GUM AND STARCH, AND APPLICATION IN SOFT CAPSULE Dec 27, 2020 Pending
Array ( [id] => 16930883 [patent_doc_number] => 20210196772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-01 [patent_title] => CONFECTIONS FOR SKIN PROTECTION: COMPOSITIONS, METHODS FOR MAKING, AND APPLICATIONS THEREOF [patent_app_type] => utility [patent_app_number] => 17/133460 [patent_app_country] => US [patent_app_date] => 2020-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7107 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17133460 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/133460
CONFECTIONS FOR SKIN PROTECTION: COMPOSITIONS, METHODS FOR MAKING, AND APPLICATIONS THEREOF Dec 22, 2020 Abandoned
Array ( [id] => 16976124 [patent_doc_number] => 20210220361 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-22 [patent_title] => SOLID DISPERSIONS OF A ERB2 (HER2) INHIBITOR [patent_app_type] => utility [patent_app_number] => 17/133094 [patent_app_country] => US [patent_app_date] => 2020-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9489 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17133094 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/133094
SOLID DISPERSIONS OF A ERB2 (HER2) INHIBITOR Dec 22, 2020 Abandoned
Array ( [id] => 17576974 [patent_doc_number] => 20220133829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-05 [patent_title] => ANTIVIRAL COMPOSITIONS AND METHODS OF USING SAME [patent_app_type] => utility [patent_app_number] => 17/127589 [patent_app_country] => US [patent_app_date] => 2020-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6665 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17127589 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/127589
Antiviral compositions and methods of using same Dec 17, 2020 Issued
Array ( [id] => 16914073 [patent_doc_number] => 20210187165 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-24 [patent_title] => Collagen Tissue Modification [patent_app_type] => utility [patent_app_number] => 17/122392 [patent_app_country] => US [patent_app_date] => 2020-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8914 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17122392 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/122392
Collagen Tissue Modification Dec 14, 2020 Pending
Array ( [id] => 17655190 [patent_doc_number] => 20220175655 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-09 [patent_title] => CALLUS LYSATE COMPRISING HIGH CONTENT OF CALLUS METABOLITE AND PREPARATION METHOD THEREOF [patent_app_type] => utility [patent_app_number] => 17/112591 [patent_app_country] => US [patent_app_date] => 2020-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12071 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17112591 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/112591
Callus lysate comprising high content of callus metabolite and preparation method thereof Dec 3, 2020 Issued
Array ( [id] => 16898977 [patent_doc_number] => 20210177893 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-17 [patent_title] => Composition and method for treating and healing Medication-Related Osteonecrosis of the Jaw (MRONJ) [patent_app_type] => utility [patent_app_number] => 17/110249 [patent_app_country] => US [patent_app_date] => 2020-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4163 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17110249 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/110249
Composition and method for treating and healing Medication-Related Osteonecrosis of the Jaw (MRONJ) Dec 1, 2020 Abandoned
Menu